iBio, Inc. (IBIO) NASDAQ

1.69

+0.4882(+40.68%)

Updated at December 08 03:46PM

Currency In USD

Valuation

Market Cap8.01M
Enterprise Value2.94M
P/E Ratio-4.13
PEG Ratio-0.21
Price/Sales Ratio51.85
Price/Book Ratio1.48
Enterprise/Revenue1.4
Enterprise/EBITDA-0.04

Fiscal Year

Fiscal YearJune 30, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-40.22
Operating Margin-40.89

Management Effectiveness

Return On Assets-0.31
Return On Equity-0.84

Income Statement

Revenue400,000
Revenue/Share0.01
Gross Profit400,000
EBITDA-17.04M
Net Income-18.38M
Diluted EPS-1.75

Balance Sheet

Total Cash49.57M
Total Cash/Share0.94
Total Debt3.29M
Total Debt/Equity0.05
Current Ratio8.39
Book Value Per Share1.06

Price History

52-Week Change-42.49
52-Week High6.89
52-Week Low0.56
Moving Average 50 Days1.12
Moving Average 200 Days1.51

Statistics

Average Volume3.17M
Shares Outstanding16.53M
% Held by Institutions34

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:20
Last Split DateNovember 29, 2023